Location: Home > Pharma China Web Edition
  • search
  • go
  • Feature Articles
  • 1/9/2024Chinese Patent Examination Guidelines 2023 – Toby's Observations
  • 1/8/2024Foreign Drug Giants Shift Strategy on China Sales as Competition Ramps...
  • 1/7/2024Christmas Present from China – Implementation Regulations of the Chin...
  • 1/7/2024Why Is TikTok Parent ByteDance Moving into Biology, Chemistry and Drug...
  • 1/7/2024Chinese Pharmaceutical Companies Chart New Paths in the Middle East (K...
  • 1/6/2024Balancing Medical Innovation and Affordability in The New Healthcare E...
  • 12/28/2023China's Revised Measures for the Administration and Registration of Fo...
  • 12/27/2023Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win (Se...
  • 12/26/20232024 Forecast: Big Pharma Reworks China Strategy, And Job Cuts Are Par...
  • 12/20/2023China NRDL 2023 Readout: the Seven-year Itch (Simon Kucher)
  • 12/15/2023China Biopharma Tracker – Novermber 2023 (PharmaDJ)
  • 12/14/2023The Impact of Experimental Data on Support of Disclosure and Inventive...
  • 12/12/2023Can China's Biotech Industry Weather Frosty US Relations? (PharmaPhoru...
  • 12/6/2023Asia Toughing Out the Uncertainties and Challenges (BioSpectrum)
  • 12/5/2023China Biotech: Investors Fear a Negative Reaction from the US (FT)
  • 12/3/2023Navigating Another New Normal in China as De-risking Starts to Bite Pr...
  • 11/24/2023China Biopharma: Charting a Path to Value Creation (McKinsey)
  • 11/24/2023China Gearing Up to Take on Pharmaceutical Giants, Drive Biotech Boom ...
  • 11/23/2023PharmaDJ's China Biopharma Tracker – October 2023 (PharmaDJ)
  • 11/22/2023Mixed Q3 For China's Innovative Firms Amid Anti-Graft Campaign (SCRIP ...
  • 11/20/2023Reflections from the 10th BioCentury-BayHelix China Summit, and Other ...
  • 11/16/2023Riding The Tide, Realize the Future: The BD Paths For Chinese Biotech ...
  • 11/16/2023Chinese Patent Office Hands Down Key Ruling on Pharma Patent Requireme...
  • 11/15/2023China CEO Interview: Gracell Aims To Enter US CAR-T Sector Through Par...
  • 11/14/2023NMPA: Quick Review of 2022 Drug Review Annual Report
  • 11/10/2023China's Strength Is Innovation on Innovation, Western Partners Are Lin...
  • 11/8/2023The Growing Pains of Chinese Biotech (In Vivo Citeline)
  • 11/6/2023Q3 Sees Fewer Pharma Financing Deals But Upticks in Ophthalmology and ...
  • 10/31/2023Big Questions Face MNC Pharma's China Business as Sustainability of th...
  • 10/31/2023Coherus Rejects 'Heavily Discounted' Pricing on Loqtorzi, the First Ch...
  • Page:3/7 Total number of articles:190: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group